Zaleski_535_StudyGuide

Page 1: Differences in Alginate Beads

High-G Alginate Beads
- Properties:
  - Thicker, more rigid, tight crosslinking
  - High gel strength, less permeable
  - Suitable for encapsulation
High-M Alginate Beads
- Properties:
  - Flexible, less rigid, looser crosslinking
  - More permeable and prone to swelling
  - Potential application in drug delivery
Key Figure Examination:
- Focus on Figure 2: Permeability of IgG in high-G vs. high-M alginate beads.
  - A: Permeability in various ionic solutions.
    - Notably, barium reduces IgG permeability in high-G; high-M remains more permeable.
    - Dark gray: Dynabeads (positive control), Black: Empty beads (negative control).
  - B: IgG diffusion rate in high-G & high-M alginate.
    - IgG diffuses slower in high-G barium-alginate yet reaches center over time.
    - Suggests barium enhances impermeability, suitable for encapsulation.

High-M alginate beads do not show reduced permeability, potentially unsuitable for immune protection applications.
Paper 2 Overview: Designing a polypeptide considering structure, function, and biomedical applications:
- Implant: Resists degradation while maintaining flexibility.
- Drug Delivery: Biodegradable based on physiological conditions (pH, temp, enzymatic activity).
- Tissue Engineering: Requires cell adhesion and growth with ECM proteins such as collagen.
Biodegradable, Biocompatible, Mechanically Sound:
- Hydrophobic AAs → structural stability.
- Hydrophilic AAs → water solubility, interaction with bodily fluids.
- Charged AAs → enhance biomolecule interactions.

Figure 2 Examination: Effect of cross-linking on particle size & encapsulation efficiency.
- A: Mean particle diameter is relatively consistent across varying cross-linkers; higher Ca2+ diameters observed.
- B: Diameter changes with increasing cross-linker concentration; Ca shows slight increase, Zn slight decrease.
- C: Minor differences in encapsulation efficiency and total VEGF released based on cross-linker; Zn shows more variance in VEGF release.
- D: No significant impact on encapsulation efficiency with increased cross-linkers.
Importance of Findings:
- Particle Size: Influences in vivo behavior (distribution, retention, interaction).
- Encapsulation Efficiency: Determines therapeutic dose delivered.
- Total VEGF Release: Critical for therapeutic efficacy; enables optimized formulations.

Figure on Cytotoxicity of Alginate Microparticles:
- A: Viability against crosslinker concentration.
- B: Zn cytotoxicity decrease upon prewashing.
- C: Varying cytotoxicity based on salt crosslinking agents with Zn.
Cytotoxicity Implications:
- Toxic ions can hinder therapeutic applications, particularly angiogenesis.
- Ca has lower cytotoxicity; barium is problematic.
- Prewashing Zn reduces ion-related toxicity.
Goals of Experiment: Achieve controlled, sustained VEGF release utilizing various crosslinking agents.
Controlling Growth Factors:
- Choice of crosslinker, concentration, and types of alginate influence release.

Photo Cross-Linking Mechanism Explained:
- Releases Ca2+ from a 'cage' using DM-n; UV light breaks coordination forming gel.
Figure 1 Examination:
- A: Top view of channel
- B: Alginate-DM-n mixed with fluor. beads in channel.
- C: Photomask position for UV exposure.
- D: Crosslinked vs. non-crosslinked channel regions after exposure.
- E: Wash with PBS removes non-crosslinked alginate.
- F: Dissolution with EDTA.
Gel Formation Process:
- DM-n’s low dissociation constant suits Ca2+ release post-UV exposure, initiating hydrogel crosslinking.
Experimental Setup:
- Selectively using UV light on channels determines efficacy of selective crosslinking and potential reversibility via EDTA.

Useful Mechanisms of PEG:
- Chain-Growth Polymerization:
  - Capable of structural applications and heterogeneous crosslinking.
  - Rapid provision of high molecular weight chains.
- Step-Growth Polymerization:
  - Utilized in cell containers; provides consistent release, stable arms, and crosslinking sites.
Role of Carboxylic Groups in Cross-Linking:
- Determines protein binding, cell adhesion, and controlled degradation.

Photodegradable Cross-Linking Mechanism:
- Allows researchers to revert crosslinked to non-crosslinked state through light exposure.
- Figures Focus:
  - A: Structures before and after cross-linking.
  - B: Shear elastic modulus evolution representing hydrogel formation.
  - C: Chemical structure breakdown post-light exposure.

Hydrogel Design for Axon Growth:
- Create spatiotemporally tunable hydrogels to control axon growth by reversing crosslinkers.

Surface Modification Approached:
- Figure 1 Examination:
  - A: Compound chemical modifications to interact with hydrogels.
  - B: Two-step polymerization demonstrating surface interaction enhancement for vessel formation.

Understanding Cross-Linking Methods:
- Physical: Temperature, crystallization, hydrogen bonding, ionic.
- Chemical: Radiation, UV-induced cross-linking.
Polymers:
- Ionic bonding (alginate), fast-reacting acrylic groups, photopolymerization methods.

Parameters Affecting Protein-Surface Interactions:
- Nature of proteins (charge, structure, size, stability).
- Medium factors (pH, ionic strength).
- Surface characteristics (topography, hydrophobicity).
Significance in Biomaterials:
- Protein behavior at surfaces impacts tissue-implant interface and cellular responses, affecting adhesion and bioactivity.

VRoman Effect:
- A protein adsorption phenomenon where high-affinity proteins displace lower-affinity ones on surfaces.

Observations on Fibrinogen Adsorption Over Time:
- Illustrated through various substrate interactions (glass, silicone rubber, etc.).
Data Measurement: Mean and SEM derived from independent experiments.

Process Description:
- Steps involve antibody attachment, protein addition, secondary antibody addition, rinsing, and measurement via spectrophotometry for protein quantification.
Key Assumption Verified:
- Structural integrity of antibodies post-adsorption ensures proper targeting.